The registry states that the Sputnik V vaccine has a modified composition, and the aim of the clinical trials is to evaluate the safety and immunogenicity of the vaccine for the prevention of coronavirus infection caused by SARS-CoV-2 Gam-COVID. -Vac virus.
Approximately 100 adult volunteers whose antigen profile has been changed will take part in the study, and it is planned to be completed on December 31, 2024.
It also appears from the records that the Russian Ministry of Health has given permission for clinical trials of the updated vaccine for children aged 12 to 17, and the end of the trial is planned for December 31, 2024.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
